Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR8 | P51685 | 20/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1339797 | 1.00 | CCR8 (0.64) | CCR8 | |
| SCHEMBL1339606 | 1.00 | CCR8 (0.64) | CCR8 | |
| SCHEMBL1338570 | 1.00 | CCR8 (0.64) | CCR8 | |
| SCHEMBL1340828 | 1.00 | CCR8 (0.64) | CCR8 | |
| SCHEMBL1337576 | 1.00 | CCR8 (0.64) | CCR8 | |
| SCHEMBL1339605 | 1.00 | CCR8 (0.64) | CCR8 | |
| SCHEMBL1337578 | 1.00 | CCR8 (0.64) | CCR8 | |
| SCHEMBL1337574 | 1.00 | CCR8 (0.64) | CCR8 | |
| SCHEMBL1338940 | 0.96 | CCR8 (0.58) | CCR8 | |
| SCHEMBL1337635 | 0.96 | CCR8 (0.58) | CCR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121406567-B | Composition and culture solution for promoting bovine gene editing cloned embryo development and application thereof | 中国农业大学 | 2026-03-27 | — | — | CN | disclosed |
| EP-4705346-A2 | ANTI-CCR8 ANTIBODIES, CONJUGATES, AND USES THEREOF | Abilita Bio, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| CN-121406567-A | Composition and culture solution for promoting bovine gene editing cloned embryo development and application thereof | 中国农业大学 | 2026-01-27 | — | — | CN | disclosed |
| US-20250092146-A1 | ANTI-CCR8 ANTIBODIES, CONJUGATES, AND USES THEREOF | ABILITA BIO, INC. D/B/A ABILITA THERAPEUTICS, INC. | 2025-03-20 | — | — | US | disclosed |
| WO-2024227083-A2 | ANTI-CCR8 ANTIBODIES, CONJUGATES, AND USES THEREOF | Abilita Bio, Inc. (US) | 2024-10-31 | — | — | WO | disclosed |
| WO-2024133292-A1 | NOVEL CCR8 ANTAGONISTS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2024-06-27 | — | — | WO | disclosed |
| US-20240175873-A1 | METHODS FOR THE DIAGNOSIS AND TREATMENT OF T CELL-LYMPHOMAS | ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (APHP) (FR) | 2024-05-30 | — | — | US | disclosed |
| EP-4313317-A1 | METHODS FOR THE DIAGNOSIS AND TREATMENT OF T CELL-LYMPHOMAS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2024-02-07 | — | — | EP | disclosed |
| WO-2024003310-A1 | METHODS FOR THE DIAGNOSIS AND TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA | Institut National de la Santé et de la Recherche Médicale (FR) | 2024-01-04 | — | — | WO | disclosed |
| CN-117177771-A | Method for diagnosing and treating T cell lymphoma | INSERM(法国国家健康医学研究院) | 2023-12-05 | — | — | CN | disclosed |
| WO-2022200303-A1 | METHODS FOR THE DIAGNOSIS AND TREATMENT OF T CELL-LYMPHOMAS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2022-09-29 | — | — | WO | disclosed |